Star Sports Medicine Co., Ltd. (HKG:1609)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
119.90
+6.90 (6.11%)
Jul 31, 2026, 4:08 PM HKT

Star Sports Medicine Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
402.75402.75327.12238.54147.9773.01
Revenue Growth
451.62%23.12%37.13%61.21%102.66%176.49%
Gross Profit
298.62298.62227.6177.31105.3148.65
Operating Income
132.2132.297.8450.0234.51-116.67
Net Income
136.97136.9795.3957.1140.34-110.25
Earnings Per Share
2.952.952.061.230.65-
EPS Growth
-43.59%66.88%88.91%--

Revenue by Geography

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Chinese Mainland
332.49332.49306.27231.88--
Other Countries/Regions
70.2770.2720.856.670.380.02
Total
402.75402.75327.12238.54147.9773.01

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
539.78539.78434.06356.37272.84214.94
Total Debt
32.6232.6222.588.3311.0610.15
Net Cash (Debt)
507.16507.16411.48348.04261.78204.78
Net Cash Growth
147.65%23.25%18.23%32.95%27.83%502.07%
Net Cash Per Share
10.9310.938.877.514.23-

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
157.12157.1294.5279.8655.818
Capital Expenditures
-34.24-34.24-27.16-17.47-8.52-3.14
Free Cash Flow
122.88122.8867.3662.3947.294.86
Free Cash Flow Growth
2428.52%82.44%7.97%31.91%873.19%-

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
74.15%74.15%69.58%74.33%71.17%66.63%
Operating Margin
32.82%32.82%29.91%20.97%23.32%-159.80%
Pretax Margin
38.28%38.28%32.88%26.96%27.46%-158.76%
Profit Margin
34.01%34.01%29.16%23.94%27.27%-151.00%
FCF Margin
30.51%30.51%20.59%26.15%31.96%6.66%